Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

378
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
378
Lung Capacity01:47

Lung Capacity

56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

384
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
384
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

343
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
343
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

415
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
415

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Mycophenolate and Azathioprine in Fibrotic Interstitial Lung Disease.

American journal of respiratory and critical care medicine·2026
Same author

Short for Their Age: Interpreting Whole-Genome Telomere Length in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Clinical Images: Skin manifestations and radiographic findings of anti-SAE1 positive dermatomyositis.

ACR open rheumatology·2026
Same author

From guideline to practice: Operationalizing telomere length testing in ILD and lung transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).

bioRxiv : the preprint server for biology·2026
Same author

A Chimeric Airway Model Enables Evaluation of Essential Genes In Vivo.

American journal of respiratory cell and molecular biology·2026

関連する実験動画

Updated: Feb 4, 2026

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
09:31

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Published on: October 16, 2016

9.9K

リウマチ性関節炎関連間質性肺疾患における末梢ヘルパーT細胞の単一細胞解析による解明

Kensuke Suga1,2, Amara Seng1,2, Changfu Yao3,4

  • 1Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

Arthritis & rheumatology (Hoboken, N.J.)
|February 2, 2026
PubMed
まとめ

研究者らは、リウマチ性関節炎関連間質性肺疾患（RA-ILD）においてユニークな免疫細胞シグネチャーを特定し、RA-ILD肺でのみ末梢ヘルパーT細胞（Tph）を発見しました。この発見は、RA-ILDの病原性に関する新たな洞察を提供します。

キーワード:
リウマチ性関節炎関連間質性肺疾患末梢ヘルパーT細胞単一細胞RNAシーケンシング免疫細胞トランスクリプトーム解析

さらに関連する動画

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.7K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.2K

関連する実験動画

Last Updated: Feb 4, 2026

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
09:31

Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients

Published on: October 16, 2016

9.9K
Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.7K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.2K

科学分野:

  • 肺医学
  • 免疫学
  • ゲノミクス

背景:

  • リウマチ性関節炎関連間質性肺疾患（RA-ILD）の病原性については、まだ十分に理解されていません。
  • RA-ILD肺における細胞およびトランスクリプトームの違いを明確にすることは、疾患メカニズムの理解に不可欠です。

研究 の 目的:

  • RA-ILD肺における上皮細胞および免疫細胞の細胞およびトランスクリプトームの状況を解明すること。
  • RA-ILDにおける肺Tph細胞と関節液Tph細胞を比較すること。

主な方法:

  • RA-ILD患者、対照群、CTD-ILD患者の肺摘出検体の単一細胞RNAシーケンシング。
  • T細胞サブクラスターと公開されている関節液T細胞データの統合解析。
  • 細胞の検証のための肺切片の免疫蛍光染色。

主要な成果:

  • 184,814個のプロファイルされた細胞から18個の異なる細胞クラスターを同定しました。
  • RA-ILD肺では肺胞I型細胞が減少し、基底細胞/線毛細胞が増加していることが観察されました。
  • RA-ILD肺でのみ末梢ヘルパーT細胞（Tph）の存在を発見し、それらは関節液Tph細胞と比較して、活性化のシグネチャーが異なり、細胞傷害性/疲弊のシグネチャーが低いことが示されました。

結論:

  • 詳細なトランスクリプトーム解析により、RA-ILD肺における主要な細胞の違いが明らかになりました。
  • 末梢ヘルパーT細胞（Tph）はRA-ILD肺の特徴です。
  • 組織間の比較により、臓器特異的なTph細胞の特徴が強調されます。